Padua Prediction Score Calculator (VTE in Medical Patients)
Venous thromboembolism risk for hospitalised medical patients with the Padua Prediction Score — active cancer, prior VTE, reduced mobility, thrombophilia, trauma, age, heart or respiratory failure, MI or stroke, infection, obesity, hormones.
How it works
Active cancer 3 + prior VTE 3 + reduced mobility 3 + thrombophilia 3 + trauma/surgery 2 + age ≥ 70 1 + heart/respiratory failure 1 + MI/stroke 1 + infection/rheumatological 1 + obesity 1 + hormones 1; ≥ 4 = high risk
Medical inpatients — those admitted with pneumonia, heart failure, sepsis or stroke rather than for surgery — account for most hospital-acquired venous thromboembolism, yet many are over- or under-treated. The Padua Prediction Score, derived in Italy and endorsed by the ACCP guidelines, splits them cleanly: below 4 the VTE rate is well under 1% and anticoagulant prophylaxis offers little; at 4 or more the rate approaches 11% and prophylaxis cuts it roughly fivefold. The four heaviest items — active cancer, prior VTE, immobility and thrombophilia — each score three, so any one of them plus a single minor factor reaches the threshold. Pair it with a bleeding-risk assessment (IMPROVE) before prescribing.
Worked example
A 74-year-old admitted with pneumonia and confined to bed for four days: mobility 3 + age 1 + infection 1 = 5 — high risk, LMWH prophylaxis.
Frequently asked questions
What about the IMPROVE score?
IMPROVE VTE is an alternative with seven items; IMPROVE Bleed assesses bleeding risk. Many hospitals pair Padua (or IMPROVE VTE) with IMPROVE Bleed.
Does prophylaxis continue after discharge?
Routine extended prophylaxis is not recommended for medical patients; trials of extended DOAC prophylaxis showed modest benefit offset by bleeding, so it is reserved for selected high-risk patients.
Related calculators
Clinical decision tool for education and for use by trained clinicians alongside judgement — not a diagnosis and not a substitute for medical assessment. Scores validated in specific populations may not apply to every patient.